270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort

• Elad Sharon,
• Razelle Kurzrock,
• Young Kwang Chae,
• Megan Othus,
• Sandip Patel,
• Sarah Fenton,
• Cristina Rodriguez,
• Adedayo Onitilo,
• Ahmad Mattour,
• Igor Rybkin,
• Jourdain Hayward,
• Christine McLeod,
• Helen Chen,
• Edward Mayerson,
• Christopher Ryan,
• Melissa Plets,
• Charles Blanke

Affiliations

Elad Sharon

Aff634 grid.48336.3a0000000419368075Cancer Therapy Evaluation ProgramNational Cancer Institute, National Institutes of Health Rockville MD USA

Razelle Kurzrock

Aff4 0000 0001 2107 4242grid.266100.3Center for Personalized Cancer Therapy and Clinical Trials Office, Division of Hematology and Oncology, Clinical Science, Department of MedicineUniversity of California San Diego Moores Cancer Center 3855 Health Sciences Drive 92093 La Jolla CA USA

Young Kwang Chae

Aff1 Developmental Therapeutics Program of the Division of Hematology Oncology, Early Phase Clinical Trials Unit 645 N. Michigan Avenue, Suite 1006 60611 Chicago IL USA

Megan Othus

2SWOG Statistical and Data Management Cen, Seattle, WA, USA

Sandip Patel

3University of California at San Diego, La Jolla, California, USA

Sarah Fenton

1Northwestern University, Chicago, IL, USA

Cristina Rodriguez

4Henry Ford Hospital, Detroit, MI, USA

Adedayo Onitilo

5Marshfield Clinic – Weston Center, Weston, WI, USA

Ahmad Mattour

4Henry Ford Hospital, Detroit, MI, USA

Igor Rybkin

4Henry Ford Hospital, Detroit, MI, USA

Jourdain Hayward

2SWOG Statistical and Data Management Cen, Seattle, WA, USA

Christine McLeod

2SWOG Statistical and Data Management Cen, Seattle, WA, USA

Helen Chen

6NIH, Bethesda, MD, USA

Edward Mayerson

2SWOG Statistical and Data Management Cen, Seattle, WA, USA

Christopher Ryan

7Oregon Health and Science University, Portland, OR, USA

Melissa Plets

2SWOG Statistical and Data Management Cen, Seattle, WA, USA

Charles Blanke

8SWOG Group Chair’s Office, Portland, OR, USA